Berkeley Lights, Inc.
5858 Horton Street
38 articles with Berkeley Lights, Inc.
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended June 30, 2020. Recent Highlights Total revenue of $10.6 million including four platform placements Completed initial public offering, raising approximately $188 million of net proceeds Second Quarter 2020 Financial Results Revenue was $10.6 million for the quarter ended June 30, 2020, representing a 10% d
Berkeley Lights Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - July 21, 2020
Berkeley Lights, Inc. announced the closing of its initial public offering of 9,315,000 shares of common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 1,215,000 shares of common stock, at a public offering price of $22.00 per share.
Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its initial public offering of 8,100,000 shares of common stock at a public offering price of $22.00 per share.
Berkeley Lights Announces Opto™ Antigen-Presenting Bead Kit to Accelerate the Expansion of Antigen-Specific T Cells Used to Develop Cell-Based Therapies
Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the Opto Antigen-Presenting Bead (APB) kit, a new reagent kit that activates and expands antigen-specific T cells in peripheral blood to create artificial T cells.
Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies
The new multiplex cytokine and cytotoxicity assays as a part of the Opto Cell Therapy Development 1.0 workflow will help users of the Berkeley Lights' platform develop cancer immunotherapies faster
Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies
Ablexis, LLC , AlivaMab Discovery Services, LLC ("ADS") and Berkeley Lights, Inc. today announced the rapid generation and recovery of sequences encoding a rich panel of human antibodies against the S1 spike protein of the S
The OptoSeq 3' mRNA Library Kit allows users of Berkeley Lights' platform to efficiently prepare cells of interest for genomic sequencing opening the door to directly link phenotype to genotype using a single system.
Berkeley Lights Launches Cell Line Development 2.0 Workflow to Find Top Clones for Complex Antibody Therapeutics
The Opto™ Cell Line Development 2.0 workflow, designed for the Beacon® optofluidic instrument, generates in just days the best production cell lines for complex antibody therapeutics with more than 99% monoclonality assurance [09-March-2020] EMERYVILLE, Calif. , March 9, 2020 /PRNewswire/ -- Today, Berkeley Lights, a leader in cell selection, launched a new workflow f
Berkeley Lights Launches Culture Station to Increase Capacity of its Beacon® and Lightning™ Optofluidic Platforms
The Culture Station increases the throughput of screened cells on the Berkeley Lights optofluidic platforms and optimizes experimental conditions, allowing users to run more independent experiments in parallel.
As the J.P. Morgan Healthcare Conference winds down for 2020, one of the big topics was the general lack of big deals. Still, there were some general trends and for today, some news.
Berkeley Lights Awarded One of The Scientist's Top Ten Innovations of 2019 for the Lightning™ Optofluidic Platform
The Scientist's award identifies exciting laboratory technologies that have the potential to foster rapid advances or generate the biggest impact on research.
Ginkgo Bioworks and Berkeley Lights Bring Unprecedented Speed and Scale to Synthetic Biology with $150MM Collaboration
Collaboration brings best-in-class technology to Ginkgo foundries, with a commitment to ongoing joint technology development
Berkeley Lights, Inc. announced the opening of a representative office in Pudong, Shanghai.
8/9/2019Biopharma companies strengthen their senior leadership teams and boards of directors.
Berkeley Lights to Launch New T Cell Functional Analytics Platform at the 34ᵗʰ Congress of the International Society for Advancement of Cytometry (CYTO)
Berkeley Lights, Inc. announced the launch of the LightningTM optofluidic platform, which directly visualizes phenotype and function of 1000s of T cells in days to help scientists address challenges in developing cancer immunotherapies.
Abveris will be launching a sister company, AbX Biologics, with an exclusive focus on therapeutic antibody discovery services.
Berkeley Lights, Inc., a leader in digital cell biology, announced that it has been named one of Fast Company's 2019 Most Innovative Companies in Biotech.
Berkeley Lights calls itself a digital cell biology company. It develops and markets tech platforms for what it calls “the intersection of biology, technology and information.”
9/4/2018Biopharm companies closed out August with a plethora of changes to executive and senior leadership positions. Let's take a look.
Shire's decision was based on a study that compared their existing CLD workflow to a workflow using the Beacon.